Skip to main content

Peer Review reports

From: Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study

Original Submission
22 Dec 2020 Submitted Original manuscript
12 Jan 2021 Author responded Author comments - Fumitaki Suzuki
Resubmission - Version 2
12 Jan 2021 Submitted Manuscript version 2
20 Mar 2021 Reviewed Reviewer Report
22 Mar 2021 Reviewed Reviewer Report
27 May 2021 Author responded Author comments - Fumitaki Suzuki
Resubmission - Version 3
27 May 2021 Submitted Manuscript version 3
3 Jun 2021 Reviewed Reviewer Report
19 Jun 2021 Reviewed Reviewer Report
28 Jul 2021 Reviewed Reviewer Report
6 Aug 2021 Reviewed Reviewer Report - Amit Goel
22 Sep 2021 Author responded Author comments - Fumitaki Suzuki
Resubmission - Version 4
22 Sep 2021 Submitted Manuscript version 4
3 Oct 2021 Reviewed Reviewer Report
28 Oct 2021 Author responded Author comments - Fumitaki Suzuki
Resubmission - Version 5
28 Oct 2021 Submitted Manuscript version 5
Publishing
2 Nov 2021 Editorially accepted
20 Dec 2021 Article published 10.1186/s12876-021-02008-9

You can find further information about peer review here.

Back to article page